Literature DB >> 26308393

The physiological effects of human immunoglobulin on severe bronchiolitis patients before and after treatment.

Yan-Hua Shan1, Yong-Gang Zhang1, Jian-Hua Zhang2, Dong Wang1, Xiao-Xia Li1, Jie Zhang1, Xi-Mei Wang1, Song-Yuan Luo1.   

Abstract

The goal of the present study is to explore the physiological effects of injected human immunoglobulin on patients with severe bronchiolitis before and after treatment. 86 young children with severe bronchiolitis were randomly divided into the observation group (43 cases) and the treatment group (43 cases). On the basis of conventional therapy, the children in the treatment group were given human immunoglobulin (400 mg/kg, 1-3 times) via intravenous injection. 60 healthy young children, as determined by a physical examination given at the Zhumadian Central Hospital, were enrolled as the control group. The T lymphocytes, cytokines, IgA, IgG, and IgM immunoglobulins in the peripheral blood of all 3 groups were measured. The clinical efficacy of the immunoglobulins to mitigate the effects of bronchiolitis and the amount of time for the reduction of symptoms to occur were observed. The serum Ca, Fe, and Zn levels of children with severe bronchiolitis were significantly lower than those of the healthy control group (p < 0.05). As such, the CD8, IgA, IgG, IgM and IFN-γ levels were also significantly lower in the children with severe bronchiolitis than in the children in the healthy control group (p < 0.05). Furthermore, the CD4, IgE, IL-4, and IL-4/IFN-γ levels and CD4/CD8 ratio were dramatically higher than in the healthy control group (p < 0.05). Serum levels of the aforementioned indicators either increased or decreased after IVIG treatment. The amount of time required for coughing, wheezing, and pulmonary rales to seize, and the duration of illness for the children with the severe bronchiolitis children was significantly shorter for those in the treatment group than for those in the observation group. Human immunoglobulin via intravenous injection showed active therapeutical effects on trace elements, T lymphocytes, and cytokines in patients with severe bronchiolitis.

Entities:  

Keywords:  IVIG; T cell subsets; clinical symptoms and signs; immunoglobulin; severe bronchiolitis; trace element

Mesh:

Substances:

Year:  2015        PMID: 26308393      PMCID: PMC4685691          DOI: 10.1080/21645515.2015.1080401

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  10 in total

1.  Function of immunoglobulin A in immunity.

Authors:  M A Kerr
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Roles of interleukin-13 and interferon-gamma in lung inflammation.

Authors:  Gabriele Grünig; Jean G Ford; Debra D Donaldson; Rajeev Venkayya; Cliff McArthur; Elisabeth Hansell; Viswanath A Kurup; Martha Warnock; Donna Rennick
Journal:  Chest       Date:  2002-03       Impact factor: 9.410

Review 3.  Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.

Authors:  Sophie Sibéril; SriRamulu Elluru; Vir-Singh Negi; Amal Ephrem; Namita Misra; Sandrine Delignat; Jagadeesh Bayary; Sébastien Lacroix-Desmazes; Michel D Kazatchkine; Srini V Kaveri
Journal:  Transfus Apher Sci       Date:  2007-08-31       Impact factor: 1.764

4.  Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis.

Authors:  Jonathan M Mansbach; Pedro A Piedra; Stephen J Teach; Ashley F Sullivan; Tate Forgey; Sunday Clark; Janice A Espinola; Carlos A Camargo
Journal:  Arch Pediatr Adolesc Med       Date:  2012-08

5.  Central importance of immunoglobulin A in host defense against Giardia spp.

Authors:  T Dianne Langford; Michael P Housley; Marianne Boes; Jianzhu Chen; Martin F Kagnoff; Frances D Gillin; Lars Eckmann
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

6.  Role of immunoglobulin A in protection against reovirus entry into Murine Peyer's patches.

Authors:  K J Silvey; A B Hutchings; M Vajdy; M M Petzke; M R Neutra
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function.

Authors:  Wendy A Neveu; Jenna L Allard; Danielle M Raymond; Lorraine M Bourassa; Stephanie M Burns; Janice Y Bunn; Charles G Irvin; David A Kaminsky; Mercedes Rincon
Journal:  Respir Res       Date:  2010-03-08

8.  Latency and persistence of respiratory syncytial virus despite T cell immunity.

Authors:  Jurgen Schwarze; Diarmund R O'Donnell; Angela Rohwedder; Peter J M Openshaw
Journal:  Am J Respir Crit Care Med       Date:  2004-01-23       Impact factor: 21.405

9.  Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4.

Authors:  Lorenzo Cosmi; Laura Maggi; Veronica Santarlasci; Manuela Capone; Elisa Cardilicchia; Francesca Frosali; Valentina Querci; Roberta Angeli; Andrea Matucci; Massimiliano Fambrini; Francesco Liotta; Paola Parronchi; Enrico Maggi; Sergio Romagnani; Francesco Annunziato
Journal:  J Allergy Clin Immunol       Date:  2010-01       Impact factor: 10.793

Review 10.  Asthma and respiratory syncytial virus infection in infancy: is there a link?

Authors:  S Z Wang; K D Forsyth
Journal:  Clin Exp Allergy       Date:  1998-08       Impact factor: 5.018

  10 in total
  1 in total

1.  Blood eosinophils, specific immunoglobulin E, and bronchiolitis severity.

Authors:  Elie J Mitri; David X Zheng; Vebhav Garg; Cassandra C Crifase; Nicole M Herrera; Janice A Espinola; Kohei Hasegawa; Carlos A Camargo
Journal:  Pediatr Pulmonol       Date:  2021-06-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.